日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO)

Talimogene laherparepvec 和 atezolizumab 在新辅助化疗后 HER2 阴性乳腺癌中的应用:一项机会窗口 II 期试验 (SOLTI-1503 PROMETEO)

Pascual, Tomás; Vidal, Maria; Cejalvo, Juan M; Vega, Estela; Sanfeliu, Esther; Villacampa, Guillermo; Ganau, Sergi; Parreño, Ana María Julve; Zamora, Esther; Miranda, Ignacio; Delgado, Ana; Bermejo, Begoña; Seguí, Elia; Brasó-Maristanty, Fara; de la Cruz-Merino, Luis; Juan, Manel; Galván, Patricia; Gonzàlez-Farré, Xavier; Chillara, Samyukta; Villagrasa, Patricia; Pfefferle, Adam D; O'Connell, Constandina E; Ferrero-Cafiero, Juan M; Oliveira, Mafalda; Perou, Charles M; Prat, Aleix

Associations of the HER2DX Genomic Test with Biological and Pathologic Features in HER2-Positive Breast Cancer

HER2DX基因组检测与HER2阳性乳腺癌生物学和病理特征的关联

Sanfeliu, Esther; Martínez-Romero, Anabel; Marín-Aguilera, Mercedes; Cobo, Sandra; González-Farré, Blanca; Hernandez-Illan, Eva; Jares, Pedro; Puig-Butillé, Joan Antón; Muñoz, Montserrat; Gómez-Bravo, Raquel; Tapia, Marta; Tebar, Cristina; Saura, Cristina; Escrivà-de-Romaní, Santiago; Soberino, Jesús; Cortés, Javier; Morales, Serafin; Amillano, Kepa; Paré, Laia; Villagrasa, Patricia; Buckingham, Wesley; Pardo, Francisco; Parker, Joel S; Brasó-Maristany, Fara; Ciruelos, Eva; Sánchez-Bayona, Rodrigo; Martinez-Sáez, Olga; Cejalvo, Juan Miguel; Prat, Aleix

Pembrolizumab and Paclitaxel in Patients with HR+/HER2- Breast Cancer with HER2-Enriched or Basal-like Subtypes

帕博利珠单抗联合紫杉醇治疗 HR+/HER2- 乳腺癌患者,包括 HER2 富集型或基底样亚型

Conte, Benedetta; Brasó-Maristany, Fara; Pascual, Tomás; Hernando, Cristina; Vázquez, Silvia; Blanch, Salvador; Oliveira, Mafalda; Virizuela, Juan Antonio; Muñoz, Montserrat; Seguí, Elia; Rodriguez-Hernandez, Adela; Vidal Losada, Maria Jesus; Galván, Patricia; Castillo, Oleguer; Blasco, Paula; Alva, Manuel; Chic, Nuria; Sanfeliu, Esther; Cano-Crespo, Sara; Salvador, Fernando; Villacampa, Guillermo; Villanueva, Lorea; Ferrero-Cafiero, Juan Manuel; Vivancos, Ana; Prat, Aleix; Ciruelos, Eva

Erratum to "Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study": [ESMO Open 9 (2024) 103989]

更正“识别激素受体阳性/HER2阴性乳腺癌新辅助化疗和内分泌治疗引起的治疗反应和分子变化的预测因子:NEOENDO转化研究”:[ESMO Open 9 (2024) 103989]

Schettini, F; Brasó-Maristany, F; Pascual, T; Lorman-Carbó, N; Nucera, S; Bergamino, M; Galván, P; Conte, B; Seguí, E; García Fructuoso, I; Gómez Bravo, R; Rodríguez, A B; Martínez-Sáez, O; Chic, N; Vidal, M; Adamo, B; González-Farre, B; Sanfeliu, E; Cebrecos, I; Mensión, E; Oses, G; Locci, M; Mollà, M; Ganau, S; Jares, P; Vidal-Sicart, S; Muñoz, M; Prat, A

Validation of the HER2DX genomic test in first-line advanced HER2-positive breast cancer treated with trastuzumab, pertuzumab, and taxane

验证 HER2DX 基因组检测在接受曲妥珠单抗、帕妥珠单抗和紫杉烷一线治疗的 HER2 阳性晚期乳腺癌患者中的应用价值

Kubeczko, Marcin; Cobo, Sandra; Sanchez-Bayona, Rodrigo; Pyciński, Bartłomiej; Soberino, Jesús; Chmielik, Ewa; Sanfeliu, Esther; Rey, Maria; Pardo, Francisco; Aguirre, Angela; Castillo, Oleguer; Lesniak, Aleksandra; Oczko-Wojciechowska, Malgorzata; Carcelero, Esther; Adamo, Barbara; Vidal, Maria; Bergamino, Milana; Maues, Julia; Villacampa, Guillermo; Paré, Laia; Villagrasa, Patricia; Ciruelos, Eva; Prat, Aleix; Jarzab, Michal; Brasó-Maristany, Fara

Activation of anti-inflammatory pathways by polyunsaturated fatty acid signaling may protect neurodevelopment in children prenatally exposed to methylmercury

多不饱和脂肪酸信号通路激活抗炎途径可能保护产前暴露于甲基汞的儿童的神经发育。

Bartra, Clara; Llop, Sabrina; Kuligowski, Julia; Albiach-Delgado, Abel; Suñol, Cristina; Rodríguez-Farré, Eduard; Ballester, Ferran; Soler-Blasco, Raquel; Jora, Beatrice; Jarné-Ferrer, Júlia; Griñán-Ferré, Christian; Vázquez, Santiago; Pallàs, Mercè; Sanfeliu, Coral

Real-world second- and third-line progression-free survival after progression on first-line CDK4/6 inhibitors in HR+/HER2- metastatic breast cancer by PAM50 intrinsic subtype: the SOLTI-1801 CDK-PREDICT study

SOLTI-1801 CDK-PREDICT 研究:在 HR+/HER2- 转移性乳腺癌患者中,一线 CDK4/6 抑制剂治疗进展后,根据 PAM50 内在亚型评估二线和三线治疗的真实世界无进展生存期

Tolosa, Pablo; García-Fructuoso, Isabel; Pascual, Tomás; Martínez-Sáez, Olga; Cejalvo, Juan Miguel; Servitja, Sonia; Fernández Abad, María; Benitez Fuentes, Javier David; Brasó-Maristany, Fara; Sanfeliu, Ester; Lema, Laura; Ruano, Yolanda; Parrilla, Lucía; Roncero, Ana María; Cobos, María Ángeles; Díaz, Irene; Centelles López, Karla Alicia; Sánchez-Bayona, Rodrigo; Alva, Manuel; Madariaga, Ainhoa; Villacampa, Guillermo; Salvador, Fernando; Sánchez-Belmonte, Agustín; Malumbres, Marcos; Prat, Aleix; Ciruelos, Eva

Exploring Sex Differences in the Relationship Between Emotion Regulation and Eating Disorders Symptoms During Early Adolescence

探讨青春期早期情绪调节与饮食失调症状之间关系的性别差异

Gámiz-Sanfeliu, María; Fernández-Capo, Maria; Rojas-Rincón, Juliana; Ampatzoglou, Aikaterini; Fernández-Cardellach, Cristina; Garcia-Casanovas, Anna; Garolera, Maite; Carballo-Márquez, Anna; Porras-Garcia, Bruno

Publisher Correction: Measuring age-dependent viscoelasticity of organelles, cells and organisms with time-shared optical tweezer microrheology

出版商更正:利用时分光光镊微流变学测量细胞器、细胞和生物体的年龄依赖性粘弹性

Català-Castro, Frederic; Ortiz-Vásquez, Santiago; Martínez-Fernández, Carmen; Pezzano, Fabio; Garcia-Cabau, Carla; Fernández-Campo, Martín; Sanfeliu-Cerdán, Neus; Jiménez-Delgado, Senda; Salvatella, Xavier; Ruprecht, Verena; Frigeri, Paolo-Antonio; Krieg, Michael

Measuring age-dependent viscoelasticity of organelles, cells and organisms with time-shared optical tweezer microrheology.

利用时分光光镊微流变学测量细胞器、细胞和生物体的年龄依赖性粘弹性

Català-Castro Frederic, Ortiz-Vásquez Santiago, Martínez-Fernández Carmen, Pezzano Fabio, Garcia-Cabau Carla, Fernández-Campo Martín, Sanfeliu-Cerdán Neus, Jiménez-Delgado Senda, Salvatella Xavier, Ruprecht Verena, Frigeri Paolo-Antonio, Krieg Michael